Orgametril (Lynestrenol)

Lynestrenol binds to progesterone receptors in the brain, suppressing the luteinising hormone surge needed for ovulation. It also induces endometrial changes that are unsuitable for implantation and thickens cervical mucus, providing multiple mechanisms that together prevent conception.

The specific dose and dosing schedule of Orgametril are determined by the prescribing clinician based on the patient’s medical history and local guidelines. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Orgametril is intended for use as a contraceptive and should not be taken during pregnancy. If pregnancy occurs, the medication should be discontinued. Limited data are available for breastfeeding; clinicians usually advise caution and may recommend alternative methods.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Orgametril (lynestrenol) is a progestogen‑only option, whereas many combined oral contraceptives contain both estrogen and progestogen. Progestogen‑only pills are often chosen for women who cannot take estrogen due to risk factors such as hypertension or migraine with aura.

Orgametril tablets should be stored at or below 25 °C, in their original packaging, and protected from moisture and direct sunlight. This helps maintain potency and ensures the product remains stable throughout its shelf life.

Orgametril is taken orally, usually once daily at the same time each day. Patients should swallow the tablet whole with water and avoid crushing or chewing it, unless otherwise directed by a healthcare professional.

The most serious risks include venous thromboembolism, severe hepatic dysfunction, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like unexplained swelling, severe abdominal pain, jaundice, or difficulty breathing.

Orgametril is contraindicated in women with a known history of thromboembolic disorders, active or past estrogen‑dependent cancers, severe liver disease, or unexplained vaginal bleeding. It should also be avoided during pregnancy and in individuals who are hypersensitive to lynestrenol or any excipients.